AddTweet This Post to Facebook hEmail this
‹‹ Go Back

Judy S. Smith, MSN, RN, CRNI

Clinical Manager - Vascular Access, Seton Healthcare Family, Austin, Texas

Judy Smith is the Clinical Manager for Vascular Access for the Seton Healthcare Family, supervising a 12-member PICC team serving seven hospitals across Central Texas. Smith has been a vascular access nurse for 12 years, placing PICCs using ultrasound, navigation, and ECG tip location technologies. She has served as principal investigator for two published studies on the topic of disinfection of needleless connectors. Smith's most recent project is advancing the practice of the PICC team to include insertion of internal jugular lines.

‹‹ Go Back

Please enter your access key

The asset you are trying to access is locked for premium users. Please enter your access key to unlock.

Email This Presentation:





Platinum Showcases

The Quest to Reduce CLABSI: Connecting Technology, Technique & Outcomes


clock5:00 PM - 6:00 PM

clockRoom: National Harbor 6-7

Judy S. Smith, MSN, RN, CRNI

Clinical Manager - Vascular Access, Seton Healthcare Family, Austin, Texas

The quest goes on: reducing the incidence of central line–associated bloodstream infections, or CLABSIs, continues to be a long-sought goal in health care. This quest carries with it the use of newer technologies, including needleless central-venous access (CVA) systems, which can serve as barriers to contamination, occlusion, and infection when properly used and maintained. This session will provide attendees with an understanding of the relationship between central-line occlusions and bloodstream infection, important bedside techniques for their prevention, and a review of the design characteristics of needleless CVA technologies that may help bring us closer to achieving the goal of eliminating CLABSIs. This session will be accredited for 1.0 contact hour of Nursing CE credit.

Learning Objectives:

  • Discuss evidence of the relationship between central vascular access (CVA) device occlusion and associated bloodstream infection
  • Identify guideline-directed interventions that can reduce the risk of CLABSI
  • Describe the design and function of needleless systems and their potential role in the prevention of CVA device occlusion and infection

Supported by: